Genomic Health, Inc. (GHDX) Tops Q4 EPS by 3c, Guides FY13
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Financial Fact:
Other income (expense), net: -174K
Today's EPS Names:
SFST, VLTO, CLIR, More
Financial Fact:
Other income (expense), net: -174K
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Genomic Health, Inc. (NASDAQ: GHDX) reported Q4 EPS of $0.06, $0.03 better than the analyst estimate of $0.03. Revenue for the quarter came in at $60.4 million versus the consensus estimate of $58.9 million.
Genomic Health, Inc. sees FY2013 revenue of $258-266 million, versus the consensus of $262.40 million.
For earnings history and earnings-related data on Genomic Health, Inc. (GHDX) click here.
Genomic Health, Inc. sees FY2013 revenue of $258-266 million, versus the consensus of $262.40 million.
For earnings history and earnings-related data on Genomic Health, Inc. (GHDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- Equity Residential (EQR) Tops Q1 EPS by 44c; offers guidance
- Renasant Corp. (RNST) Tops Q1 EPS by 3c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
